CN Patent
CN115925696A — 一种1-氰基-2-苯基乙基甲酰胺衍生物及其用途
Assigned to Ruishi Biomedical Co ltd · Expires 2023-04-07 · 3y expired
What this patent protects
本公开涉及一种1‑氰基‑2‑苯基乙基甲酰胺衍生物及其用途。具体而言,提供一种如式I所示化合物或其可药用盐,其中R 1 、R 3 、n如本文本中所定义。
USPTO Abstract
本公开涉及一种1‑氰基‑2‑苯基乙基甲酰胺衍生物及其用途。具体而言,提供一种如式I所示化合物或其可药用盐,其中R 1 、R 3 、n如本文本中所定义。
Drugs covered by this patent
- Brinsupri (BRENSOCATIB) · Insmed Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.